Investor List:

Top Pharmaceuticals Seed Investors in London (33)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Pablo Lubroth, Investor at Hummingbird Ventures
Pablo Lubroth
Sweet spot: $2.8M
Range: $500K - $5.0M
Investors in London, Investors in New York (NY)
Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Series A), Investors in DeepTech (Series B), Investors in Therapeutics (Seed), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Series B), Investors in Digital Health (Pre-seed), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Therapeutics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in DeepTech (Series A), Investors in Digital Health (Pre-seed), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in DeepTech (Seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in DeepTech (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Pre-seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Digital Health (Series B), Investors in BioTech (Pre-seed), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in London (Other Lists), Investors in New York City (Other Lists)
Photo of Hussein Kanji, Analyst at Hoxton Ventures
Hussein Kanji
Sweet spot: $2.0M
Range: $1M - $3.0M
Investors in United Kingdom, Investors in London
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Retail (Pre-seed), Investors in AI (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Analytics (Pre-seed), Investors in AI (Series A), Investors in AI (Seed), Investors in Security (Pre-seed), Investors in Analytics (Series A), Investors in Digital Health (Series A), Investors in Enterprise Applications (Series A), Investors in Analytics (Seed), Investors in Security (Series A), Investors in Retail (Series A), Investors in Retail (Seed), Investors in Digital Health (Seed), Investors in Security (Seed), Investors in Enterprise Applications (Seed), Investors in Marketplaces (Series A), Investors in Consumer Internet (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in SaaS (Pre-seed), Investors in Marketplaces (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in SaaS (Series A), Investors in Consumer Internet (Series A), Investors in SaaS (Seed), Investors in Consumer Internet (Seed), Investors in Retail (Pre-seed), Investors in Enterprise Applications (Pre-seed), Investors in Security (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Pre-seed), Investors in AI (Pre-seed), Investors in Retail (Series A), Investors in Analytics (Pre-seed), Investors in Retail (Seed), Investors in Security (Series A), Investors in Enterprise Applications (Series A), Investors in Analytics (Series A), Investors in AI (Series A), Investors in Security (Seed), Investors in Enterprise Applications (Seed), Investors in AI (Seed), Investors in Digital Health (Series A), Investors in Marketplaces (Pre-seed), Investors in Analytics (Seed), Investors in Digital Health (Seed), Investors in Consumer Internet (Pre-seed), Investors in Marketplaces (Series A), Investors in Diverse Investors (Other Lists), Investors in SaaS (Pre-seed), Investors in London (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Marketplaces (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in SaaS (Series A), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in SaaS (Seed)
Photo of Robert Thong, General Partner at Selvedge Venture
Robert Thong
Selvedge Venture·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Enterprise Applications (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Enterprise Applications (Series A), Investors in BioTech (Pre-seed), Investors in Digital Health (Series A), Investors in Health IT (Pre-seed), Investors in Enterprise (Pre-seed), Investors in BioTech (Series A), Investors in Enterprise Applications (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Seed), Investors in Enterprise (Series A), Investors in Health & Hospital Services (Seed), Investors in Enterprise (Seed), Investors in Enterprise Applications (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Pre-seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Enterprise (Pre-seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in London (Other Lists), Investors in Enterprise (Series A), Investors in Enterprise (Seed)
Photo of Timothy Haines, Managing Partner at Abingworth
Timothy Haines
Abingworth·Managing Partner
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in London
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in London (Other Lists)
Photo of Loukas Saridis, Managing Director at Yarrow Capital
Loukas Saridis
Yarrow Capital·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Logistics (Series A), Investors in Logistics (Seed), Investors in SMB Software (Series A), Investors in SMB Software (Seed), Investors in Logistics (Series A), Investors in SMB Software (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Logistics (Seed), Investors in SMB Software (Seed), Investors in London (Other Lists)
Photo of Bali Muralidhar, Managing Partner at Abingworth
Bali Muralidhar
Abingworth·Managing Partner
Sweet spot: $22.5M
Range: $15.0M - $30.0M
Investors in London
Photo of Noah Berkson, Managing Partner at Candor Ventures
Noah Berkson
Candor Ventures·Managing Partner
Sweet spot: $200K
Range: $100K - $750K
Investors in Los Angeles (CA), Investors in Chicago (IL), Investors in Miami (FL), Investors in London
Investors in Human Capital/HRTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Human Capital/HRTech (Pre-seed), Investors in Human Capital/HRTech (Seed), Investors in Sales & CRM (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Sales & CRM (Seed), Investors in Sales & CRM (Pre-seed), Investors in Human Capital/HRTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Human Capital/HRTech (Pre-seed), Investors in Insurance (Pre-seed), Investors in AgTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Human Capital/HRTech (Seed), Investors in Human Capital/HRTech (Seed), Investors in AgTech (Pre-seed), Investors in Sales & CRM (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Human Capital/HRTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Sales & CRM (Seed), Investors in Sales & CRM (Pre-seed), Investors in Insurance (Seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Insurance (Pre-seed), Investors in AgTech (Pre-seed), Investors in AgTech (Seed), Investors in Marketplaces (Pre-seed), Investors in Sales & CRM (Seed), Investors in Insurance (Pre-seed), Investors in AgTech (Seed), Investors in AgTech (Pre-seed), Investors in Sales & CRM (Seed), Investors in Insurance (Pre-seed), Investors in Real Estate/PropTech (Pre-seed), Investors in Real Estate/PropTech (Seed), Investors in Insurance (Seed), Investors in AgTech (Seed), Investors in Marketplaces (Seed), Investors in Marketplaces (Pre-seed), Investors in Real Estate/PropTech (Seed), Investors in Insurance (Seed), Investors in Real Estate/PropTech (Pre-seed), Investors in SaaS (Pre-seed), Investors in AgTech (Seed), Investors in FinTech (Pre-seed), Investors in Marketplaces (Pre-seed), Investors in Real Estate/PropTech (Seed), Investors in FinTech (Pre-seed), Investors in Insurance (Seed), Investors in SaaS (Pre-seed), Investors in SaaS (Pre-seed), Investors in Real Estate/PropTech (Seed), Investors in SaaS (Seed), Investors in Marketplaces (Seed), Investors in FinTech (Seed), Investors in Marketplaces (Seed), Investors in FinTech (Pre-seed), Investors in FinTech (Seed), Investors in Marketplaces (Pre-seed), Investors in Human Capital/HRTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in FinTech (Pre-seed), Investors in SaaS (Seed), Investors in SaaS (Seed), Investors in SaaS (Pre-seed), Investors in Sales & CRM (Pre-seed), Investors in Marketplaces (Seed), Investors in Human Capital/HRTech (Seed), Investors in FinTech (Seed), Investors in AgTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in SaaS (Seed), Investors in Insurance (Pre-seed), Investors in FinTech (Seed), Investors in Sales & CRM (Seed), Investors in Real Estate/PropTech (Pre-seed), Investors in AgTech (Seed), Investors in Insurance (Seed), Investors in Marketplaces (Pre-seed), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Real Estate/PropTech (Seed), Investors in Midwest (Other Lists), Investors in SaaS (Pre-seed), Investors in Marketplaces (Seed), Investors in FinTech (Pre-seed), Investors in Los Angeles / Southern California (Other Lists), Investors in London (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in SaaS (Seed), Investors in FinTech (Seed)
Photo of Andrew Kozlov, Managing Partner at 4BIO Capital
Andrew Kozlov
4BIO Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in London (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed)